angiotensin ii, des-asp(1)-des-arg(2)-ile(5)- has been researched along with Alzheimer Disease in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Hamel, E; Martinot, P; Royea, J | 1 |
Harding, JW; Kawas, LH; Wright, JW | 1 |
Hallberg, M | 1 |
Albiston, AL; Ascher, DB; Chai, SY; Cherny, RA; Cromer, BA; Morton, CJ; Parker, MW; Volitakis, I | 1 |
Albiston, AL; Chai, SY; Fernando, R; Peck, GR; Ye, S | 1 |
3 review(s) available for angiotensin ii, des-asp(1)-des-arg(2)-ile(5)- and Alzheimer Disease
Article | Year |
---|---|
The development of small molecule angiotensin IV analogs to treat Alzheimer's and Parkinson's diseases.
Topics: Alzheimer Disease; Angiotensin II; Animals; Humans; Memory Disorders; Parkinson Disease; Receptors, Angiotensin; Renin-Angiotensin System | 2015 |
Targeting the insulin-regulated aminopeptidase/AT4 receptor for cognitive disorders.
Topics: Alzheimer Disease; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Cognition Disorders; Cystinyl Aminopeptidase; Drug Delivery Systems; Drug Discovery; Humans; Ligands; Models, Biological; Molecular Structure; Receptors, Angiotensin | 2009 |
Alzheimer's, angiotensin IV and an aminopeptidase.
Topics: Alzheimer Disease; Aminopeptidases; Angiotensin II; Animals; Binding Sites; Humans | 2004 |
2 other study(ies) available for angiotensin ii, des-asp(1)-des-arg(2)-ile(5)- and Alzheimer Disease
Article | Year |
---|---|
Memory and cerebrovascular deficits recovered following angiotensin IV intervention in a mouse model of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Angiotensin II; Animals; Disease Models, Animal; Hippocampus; Humans; Infusions, Intraventricular; Memory; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neurovascular Coupling | 2020 |
Regulation of insulin-regulated membrane aminopeptidase activity by its C-terminal domain.
Topics: Alzheimer Disease; Angiotensin II; Binding Sites; Catalytic Domain; Cystinyl Aminopeptidase; Databases, Protein; Humans; Hydrolysis; Kinetics; Models, Molecular; Molecular Targeted Therapy; Peptide Fragments; Protease Inhibitors; Protein Interaction Domains and Motifs; Protein Structure, Tertiary; Recombinant Proteins; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Zinc | 2011 |